{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:39:44Z","timestamp":1783042784788,"version":"3.54.6"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31271455"],"award-info":[{"award-number":["31271455"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31200861"],"award-info":[{"award-number":["31200861"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31571178"],"award-info":[{"award-number":["31571178"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81200308"],"award-info":[{"award-number":["81200308"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.atherosclerosis.2015.11.009","type":"journal-article","created":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T22:30:22Z","timestamp":1448317822000},"page":"179-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["SAP deficiency mitigated atherosclerotic lesions in ApoE\u2212\/\u2212 mice"],"prefix":"10.1016","volume":"244","author":[{"given":"Lingyun","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiling","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingwen","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxing","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangchao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib1","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib2","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1161\/CIRCULATIONAHA.107.754614","article-title":"Contribution of macromolecular structure to the retention of low-density lipoprotein at arterial branch points","volume":"117","author":"Kwon","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib4","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/imr.12218","article-title":"Macrophage phenotypes in atherosclerosis","volume":"262","author":"Colin","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1517\/14728214.2013.801453","article-title":"Emerging anti-inflammatory drugs for atherosclerosis","volume":"18","author":"Berman","year":"2013","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cca.2013.06.006","article-title":"Foam cells in atherosclerosis","volume":"424","author":"Yu","year":"2013","journal-title":"Clin. Chimica Acta Int. J. Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib8","first-page":"86","article-title":"The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis","volume":"39","author":"Rudijanto","year":"2007","journal-title":"Acta Medica Indones."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib9","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/MOL.0b013e32830d5f09","article-title":"Emigration of monocyte-derived cells to lymph nodes during resolution of inflammation and its failure in atherosclerosis","volume":"19","author":"Randolph","year":"2008","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/138161211795049750","article-title":"Pentraxins and atherosclerosis: the role of ptx3","volume":"17","author":"Garlanda","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/978-1-4419-0901-5_7","article-title":"Pattern recognition by pentraxins","volume":"653","author":"Agrawal","year":"2009","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.immunol.23.021704.115756","article-title":"Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility","volume":"23","author":"Garlanda","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-007-9126-7","article-title":"Pentraxins in innate immunity: from c-reactive protein to the long pentraxin ptx3","volume":"28","author":"Mantovani","year":"2008","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00441-010-1018-0","article-title":"Pentraxins in innate immunity: lessons from ptx3","volume":"343","author":"Deban","year":"2011","journal-title":"Cell tissue Res."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib15","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/9544","article-title":"Serum amyloid p component controls chromatin degradation and prevents antinuclear autoimmunity","volume":"5","author":"Bickerstaff","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib16","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1073\/pnas.94.6.2575","article-title":"Transgenic mice expressing rabbit c-reactive protein are resistant to endotoxemia","volume":"94","author":"Xia","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib17","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.4049\/jimmunol.166.11.6735","article-title":"Serum amyloid p component binds to fc gamma receptors and opsonizes particles for phagocytosis","volume":"166","author":"Bharadwaj","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12016-008-8098-6","article-title":"Pentraxins, anti-pentraxin antibodies, and atherosclerosis","volume":"37","author":"Bassi","year":"2009","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/bbrc.1998.8248","article-title":"Serum amyloid p component associates with high density lipoprotein as well as very low density lipoprotein but not with low density lipoprotein","volume":"244","author":"Li","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib20","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/01.ATV.0000201930.10103.be","article-title":"Prevalence and pathology of amyloid in atherosclerotic arteries","volume":"26","author":"Rocken","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib21","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/01.ATV.0000254150.97741.fe","article-title":"Serum amyloid p and cardiovascular disease in older men and women: results from the cardiovascular health study","volume":"27","author":"Jenny","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib22","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1194\/jlr.M700098-JLR200","article-title":"Serum amyloid p colocalizes with apolipoproteins in human atheroma: functional implications","volume":"48","author":"Stewart","year":"2007","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib23","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/ATVBAHA.114.304365","article-title":"Inactivation of pi3kdelta induces vascular injury and promotes aneurysm development by upregulating the ap-1\/mmp-12 pathway in macrophages","volume":"35","author":"Zheng","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"Suppl.\u00a0l","key":"10.1016\/j.atherosclerosis.2015.11.009_bib24","doi-asserted-by":"crossref","first-page":"S277","DOI":"10.1194\/jlr.R800063-JLR200","article-title":"Regulation of macrophage function in inflammation and atherosclerosis","volume":"50","author":"Shibata","year":"2009","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cmet.2006.06.007","article-title":"A\u00a0cd36-dependent signaling cascade is necessary for macrophage foam cell formation","volume":"4","author":"Rahaman","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/01.ATV.0000201041.14438.8d","article-title":"Oxldl-igg immune complexes induce survival of human monocytes","volume":"26","author":"Oksjoki","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib27","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/sj.gt.3302706","article-title":"Human monocytes expressing a cea-specific chimeric cd64 receptor specifically target cea-expressing tumour cells in\u00a0vitro and in\u00a0vivo","volume":"13","author":"Biglari","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.atherosclerosis.2010.02.003","article-title":"Conjugated linoleic acid suppresses the migratory and inflammatory phenotype of the monocyte\/macrophage cell","volume":"211","author":"McClelland","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.plipres.2011.04.002","article-title":"Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy","volume":"50","author":"McLaren","year":"2011","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib31","doi-asserted-by":"crossref","first-page":"49982","DOI":"10.1074\/jbc.M209649200","article-title":"Scavenger receptors class a-i\/ii and cd36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages","volume":"277","author":"Kunjathoor","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib32","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1038\/emm.2014.38","article-title":"Cd36, a scavenger receptor implicated in atherosclerosis","volume":"46","author":"Park","year":"2014","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib33","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.cardiores.2007.03.010","article-title":"Cd36 and macrophages in atherosclerosis","volume":"75","author":"Collot-Teixeira","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1042\/BSR20080045","article-title":"Cd36 n-terminal cytoplasmic domain is not required for the internalization of oxidized low-density lipoprotein","volume":"28","author":"McDermott-Roe","year":"2008","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cmet.2005.03.005","article-title":"Lipoproteins, macrophage function, and atherosclerosis: beyond the foam cell?","volume":"1","author":"Rader","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib36","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1189\/jlb.0112033","article-title":"Fcgammari mediates serum amyloid p inhibition of fibrocyte differentiation","volume":"92","author":"Crawford","year":"2012","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1126\/scitranslmed.3000111","article-title":"Serum amyloid p inhibits fibrosis through fc gamma r-dependent monocyte-macrophage regulation in\u00a0vivo","volume":"1","author":"Castano","year":"2009","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib38","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.RES.0000250556.07796.6c","article-title":"Fcgamma receptor deficiency confers protection against atherosclerosis in apolipoprotein e knockout mice","volume":"99","author":"Hernandez-Vargas","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib39","doi-asserted-by":"crossref","first-page":"844","DOI":"10.5551\/jat.3905","article-title":"High-density lipoprotein inhibits the uptake of modified low- density lipoprotein and the expression of cd36 and fcgammari","volume":"17","author":"Carvalho","year":"2010","journal-title":"J.\u00a0Atheroscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib40","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1126\/science.1101909","article-title":"Requirement of jnk2 for scavenger receptor a-mediated foam cell formation in atherogenesis","volume":"306","author":"Ricci","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib41","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nm1102-1235","article-title":"The macrophage foam cell as a target for therapeutic intervention","volume":"8","author":"Li","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib42","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ecl.2014.08.001","article-title":"Beginning to understand high-density lipoproteins","volume":"43","author":"Santos-Gallego","year":"2014","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib43","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1161\/ATVBAHA.110.207977","article-title":"Cholesteryl ester transfer protein polymorphism (taqib) associates with risk in postinfarction patients with high c-reactive protein and high-density lipoprotein cholesterol levels","volume":"30","author":"Corsetti","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib44","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1182\/blood-2002-07-2209","article-title":"Platelet p-selectin facilitates atherosclerotic lesion development","volume":"101","author":"Burger","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib45","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1084\/jem.191.1.189","article-title":"P-selectin or intercellular adhesion molecule (icam)-1 deficiency substantially protects against atherosclerosis in apolipoprotein e-deficient mice","volume":"191","author":"Collins","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib46","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/ATVBAHA.107.161174","article-title":"Chemokines in atherosclerosis: an update","volume":"28","author":"Zernecke","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib47","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1161\/ATVBAHA.108.173898","article-title":"Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability","volume":"28","author":"Newby","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib48","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cmet.2007.06.010","article-title":"Ppargamma activation primes human monocytes into alternative m2 macrophages with anti-inflammatory properties","volume":"6","author":"Bouhlel","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib49","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/CIRCRESAHA.109.215715","article-title":"Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via nrf2","volume":"107","author":"Kadl","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib50","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11883-014-0401-9","article-title":"Pathophysiology of acute coronary syndrome","volume":"16","author":"Santos-Gallego","year":"2014","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib52","doi-asserted-by":"crossref","first-page":"11629","DOI":"10.1074\/jbc.M111.338673","article-title":"Endoplasmic reticulum stress controls m2 macrophage differentiation and foam cell formation","volume":"287","author":"Oh","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib53","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.4049\/jimmunol.1002315","article-title":"Macrophage differentiation and polarization via phosphatidylinositol 3-kinase\/akt-erk signaling pathway conferred by serum amyloid p component","volume":"187","author":"Zhang","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib54","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","article-title":"Hdl and cardiovascular disease: atherogenic and atheroprotective mechanisms","volume":"8","author":"Navab","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib55","first-page":"3","article-title":"Modelos experimentales de aterosclerosis","volume":"13","author":"Santos-Gallego","year":"2013","journal-title":"Rev. Esp. Cardiol. Supl."},{"key":"10.1016\/j.atherosclerosis.2015.11.009_bib56","first-page":"503","article-title":"Mouse models of experimental atherosclerosis","volume":"55","author":"Jawien","year":"2004","journal-title":"J.\u00a0Physiol. Pharmacol. Off. J. Pol. Physiol. Soc."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015302057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015302057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T20:48:24Z","timestamp":1567370904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915015302057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":56,"alternative-id":["S0021915015302057"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.11.009","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SAP deficiency mitigated atherosclerotic lesions in ApoE\u2212\/\u2212 mice","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}